Open Access Open Access  Restricted Access Subscription Access

Neuropharmacological links Between Diabetes and Alzheimer’s Disease: Molecular crosstalk and Therapeutic Potential of Flavonoids

Kajal .

Abstract


Objectives: To analyze the  molecular and neuropharmacological links between Diabetes and Alzheimer’s Disease and to evaluate the therapeutic potential of flavonoids in diabetes-associated Alzheimer’s disease (DAAD).

Material and Method: Using indexed biomedical literature, a narrative evaluation of experimental, preclinical, and clinical studies addressing insulin resistance, oxidative stress, neuroinflammation, amyloid pathology, and flavonoid-mediated neuroprotection in DM and AD was carried out.

Result: DM and AD share comparable pathophysiological pathways including insulin resistance, mitochondrial dysfunction, oxidative stress, chronic inflammation, advanced glycation end products (AGEs), and decreased SIRT1/AMPK signalling. Brain insulin resistance relates to amyloid-β build up and tau hyperphosphorylation. In experimental models, flavonoids including quercetin, rutin, kaempferol, genistein, luteolin, naringenin, and hesperidin demonstrate insulin-sensitizing, anti-inflammatory, anti-amyloidogenic, and anticholinesterase properties.

Conclusion: Flavonoids are prospective multi-target therapeutic agents for DAAD, as they modulate shared molecular pathways of DM and AD. Nevertheless, in order to verify the efficacy, safety, and optimal administration strategies, well-designed clinical trials are necessary.


Full Text:

PDF

References


Hollman, P. C., de Vries, J. H., van Leeuwen, S. D., Menglers, M. J., & Katan, M. B. (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. The American Journal of Clinical Nutrition, 62(6), 1276–1282.

Szwajgier, D. (2015). Anticholinesterase activity of selected phenolic acids and flavonoids—interaction testing in model solutions. Annals of Agricultural and Environmental Medicine, 22(4).

Ahmed, O., Abdel Moneim, A., Yazid, I., & Mahmoud, A. (2010). Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats. Diabetologia Croatica, 39(1), 15.

Hossain, M. K., et al. (2014). Antiviral activity of 3,4′-dihydroxyflavone on influenza A virus. Journal of Microbiology, 52(6), 521–526. https://doi.org/10.1007/s12275-014-4212-z

Ergul, A. (2011). Endothelin-1 and diabetic complications: Focus on the vasculature. Pharmacological Research, 63(6), 477–482. https://doi.org/10.1016/j.phrs.2011.01.012

Graf, B. A., Milbury, P. E., & Blumberg, J. B. (2005). Flavonols, flavones, flavanones, and human health: Epidemiological evidence. Journal of Medicinal Food, 8(3), 281–290. https://doi.org/10.1089/jmf.2005.8.281

Ghorbani, A. (2017). Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine & Pharmacotherapy, 96, 305–312.

Devi, K. P., Shanmuganathan, B., Manayi, A., Nabavi, S. F., & Nabavi, S. M. (2017). Molecular and therapeutic targets of genistein in Alzheimer’s disease. Molecular Neurobiology, 54(9), 7028–7041. https://doi.org/10.1007/s12035-016-0215-6

Bang, O. Y., et al. (2004). Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiology of Disease, 16(1), 21–28. https://doi.org/10.1016/j.nbd.2003.12.017

Bachman, D. L., et al. (1992). Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology, 42(1), 115. https://doi.org/10.1212/WNL.42.1.115


Refbacks

  • There are currently no refbacks.